A carregar...
A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin(® )(Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design
BACKGROUND: The management of neovascular age-related macular degeneration (nAMD) has been transformed by the introduction of agents delivered by intravitreal injection which block the action of vascular endothelial growth factor-A (anti-VEGF agents). One such agent in widespread use is bevacizumab...
Na minha lista:
Main Authors: | , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
BioMed Central
2008
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2576049/ https://ncbi.nlm.nih.gov/pubmed/18854025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-9-56 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|